	Bioinformatics-Driven Discovery of AÎ²-Targeted Therapeutics and Diagnostic Biomarkers for Alzheimer's Disease. Biomed Res Int Li X, Liu X, Song X, Zhou Y, Yang D, Wang Y, Mao S, Rang X, Hong X, Wang X, Yue H, Wang D, Zhang X. PMID: 42752992 [PubMed - indexed for MEDLINE]
	A Lipoylation-PDH-TCA Transcriptional Deficit in the Alzheimer's Disease Cortex - Donor-level Multi-cohort Evidence with Neuronal-composition, Disease-specificity and Matched-null Controls. J Mol Neurosci Zhang T, Chen X, Wang Y, Wang Y. PMID: 42752765 [PubMed - indexed for MEDLINE]
	Amyloid-beta-targeting monoclonal antibodies in early Alzheimer's disease: a cochrane review summary and appraisal for the neurological community. Neurol Sci Santos DH, da Silva AMP. PMID: 42752707 [PubMed - indexed for MEDLINE]
	Cohort profile: a community-based prospective cohort study of Alzheimer's disease and related dementias in the Democratic Republic of Congo. Alzheimers Dement Behav Socioecon Aging Ikanga J, Obenauf C, Patel SS, Schwinne M, Gikelekele G, Epenge E, Potshi JM, Tomadia T, Kazadi J, Kavugho I, Santolini GL, Nkosi A, Sabowa FM, Musewu BM, Mawisa E, Tsangu JP, Beya FMK, Mampunza S, Mananga L, Bukabau J, Teunissen CE, Karikari T, Gross AL, Rojas JC, Alonso A. PMID: 42751573 [PubMed]
	Alzheimer's disease: genetic background in the era of next-generation sequencing technologies. Brain Commun Lukyova L, Zatkova A, Minarik J, Holesova Z, Budis J, Kucharik M, Benes V, Gazdarica J, Szemes T. PMID: 42751194 [PubMed]
	Rethinking tau-targeted therapy in Alzheimer's disease: Toward a dual biomarker strategy. Alzheimers Dement Teunissen CE, Pini L, Imbimbo BP. PMID: 42750203 [PubMed - indexed for MEDLINE]
	Operationalizing Alzheimer's disease trials in the era of targeted therapies. Alzheimers Dement Pillai JA, Alladi S, Appleby BS, Brosch JR, Frederiksen KS, Galasko D, Lopez OL, Leverenz JB, Saykin AJ, Schott JM, Seshadri S, Tousi B, Wolk DA. PMID: 42750195 [PubMed - indexed for MEDLINE]
	Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives. Mol Neurobiol Begum MY, Rajkumar M, Govindaraj P, Velmani S, Rajkumar P, Sudha PN, Alhamod M, Alotaibi H. PMID: 42749965 [PubMed - indexed for MEDLINE]
	Neuropsychiatric symptoms as predictors of progression to Alzheimer's disease in mild cognitive impairment: A comparative meta-analysis of apathy, depression, and anxiety. Int Psychogeriatr Sun Y, Cao Y, Ma J, Li W, Li H, Tan Z. PMID: 42749536 [PubMed - as supplied by publisher]
	Genetic susceptibility of Alzheimer's disease associated with APOE polymorphism: systematic review and bibliometric study. J Genet Eng Biotechnol Amukti DP, Kusumawardani N, Pratami RI, Purwanto BD, Rukhama RA, Akbar I, Sarwadhamana RJ, Aditya RA, Yuliani S. PMID: 42749454 [PubMed]
	Alzheimer's disease burden in China (ABC) study: protocol for a nationwide multicentre cross-sectional and prospective cohort study. BMJ Open Wang Y, Qin Q, Yang K, Yu M, Yao Y, Gong C, Guo J, Yang L, Tang Y. PMID: 42749375 [PubMed - indexed for MEDLINE]
	Inflection points and transitions in Alzheimer's disease. Nature De Strooper B, Karran E. PMID: 42749285 [PubMed - as supplied by publisher]
	From systems to cells: metabolic mechanisms underlying risk divergence in Alzheimer's disease and amyotrophic lateral sclerosis. Neurosci Biobehav Rev Knezovic A, Krsnik A, Homolak J, Perhoc AB, Deskin A, Virag D, Salkovic-Petrisic M, Barilar JO. PMID: 42749235 [PubMed - as supplied by publisher]
	Unlocking the Potential of Isatin Scaffolds in Acetylcholinesterase Inhibition. Arch Pharm (Weinheim) Tharwat T, El-Nassan HB, Adly ME, Kamel MM. PMID: 42748401 [PubMed - indexed for MEDLINE]
	Emerging therapeutic targets beyond amyloid and tau in Alzheimer's Disease: Implications for lifestyle, metabolism and preventive medicine. Wiad Lek Izhytska N, Sobczyk KA, Ogrodnik KW, Mazurkiewicz M, Malentowicz D, Szafraniec NJ, Bro, Sa, Pastuszka M. PMID: 42748320 [PubMed - indexed for MEDLINE]
	Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study. Ann Neurol Urso D, Giannelli T, Tafuri B, Giannoni-Luza S, Gnoni V, Giugno A, Vilella D, Zecca C, De Blasi R, Nigro S, Aarsland D, Logroscino G. PMID: 42747246 [PubMed - as supplied by publisher]
	Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment. Drug Dev Res Yadav P, Mishra D, Singh R. PMID: 42747078 [PubMed - indexed for MEDLINE]
	Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions. J Alzheimers Dis Sánchez-Soblechero A, Villarejo A, Carreras MT, Berbel Á, Puertas C, Fernández-Bullido Y, Vieira A, Gundín I, Blanco-Palmero V, González-Sánchez M, Llamas S, Lapeña T, de Luis P, Lucio B, Ibáñez MD, Heredia P, Grandas F, Olazarán J. PMID: 42746979 [PubMed - as supplied by publisher]
	Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer's disease: a 24-month prospective cohort study. J Clin Exp Neuropsychol Russo MJ, Bueri J, Alba-Ferrara L, Sevlever G, Allegri RF. PMID: 42746710 [PubMed - as supplied by publisher]
	Designing intranasal formulations for Alzheimer's disease: A material-based perspective. Tzu Chi Med J Chen YS, Huang HY. PMID: 42746628 [PubMed]

Articles 1 - 20 / 72285

Page 1 of 3615



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy